EUVIMED · CrossrefZeitschrift
Journal of Pharmacokinetics and Pharmacodynamics
ISSN 1567-567X · Springer Science and Business Media LLC
Neueste Artikel
Modified frequency-based sensitivity analysis for oscillatory system models
Exact FOCE-I optimization on stiff manifolds via differentiable programming in JAX
High-dimensional neural ODE model to characterize clinical pharmacokinetics of MMAE-based antibody-drug conjugates
Quantitative systems pharmacology modeling identifies synthetic lethality opportunities with DNA damage response inhibitors in ATM-deficient chronic lymphocytic leukemia – a computational simulation study
Construction of a translational whole-body physiologically based pharmacokinetic model to investigate the biodistribution of lipid nanoparticle-based mRNA therapeutics for intracellular protein targets
External validation of population pharmacokinetic models of adalimumab in adult patients with inflammatory bowel disease: towards model-informed precision dosing
A missed synthesis from the 1930s: Teorell, Mayneord, and the origins of physiological PK–TGI modelling
Adaptive PK/PD model optimization: a comparative analysis of bounded optimization methods for individual BIS prediction
Mechanistic modeling of FcRn-dependent IgG drug interactions: Clinical applications and dosing implications
Multi-objective optimization in population pharmacokinetic model selection and optimization: application of NSGA-II in pyDarwin
Optimizing Subcutaneous Antibody Dosing Regimens Through Operating Space Maps: rHuPH20 Case Study
Exposure-safety analyses of talazoparib in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) in the TALAPRO-2 trial
Pediatric oral cavity physiologically based pharmacokinetic model to predict pharmacokinetics of mucoadhesive atropine gel to treat sialorrhea
Personalized prophylactic therapy optimization in hemophilia A using a hybrid PK-PD-TTE model and deep RL
Comparing heavy-tailed residual error models for outlier handling in population PK modeling
A hybrid PKPD agent-based model of the tumour immune interaction: effects of anti-cancer combination therapy
Early exposure-response modeling of an interferon-beta monoclonal antibody (dazukibart) in adults with dermatomyositis
Modeling, Simulation, and Extrapolation to Optimize Pediatric Development Plan: Sarilumab Polyarticular-Course juvenile arthritis Application
Mitigating antibiotic resistance from missed doses
Utility of a physiologically-based pharmacokinetic model for investigating time-dependent variability in the fetal-to-maternal plasma concentration ratio of digoxin
Tracer kinetic modeling of a 14 kDa anti-CD8 PET tracer (2C8v144) for in vivo estimation of CD8 expression in tissue and blood, binding affinity, and total body receptor occupancy
Development of a population pharmacokinetics model and an R-Shiny simulation platform for moxifloxacin pharmacokinetics in non-human primates
A structure-preserving hybrid learning framework for compartmental pharmacokinetic models
Uncertainty undermines the validity of antimicrobial pharmacodynamics
Assessing the impact of bacterial heterogeneity on bacteriophage population dynamics
QT interval prolongation: clinical assessment, risk factors and quantitative pharmacological considerations
Advancing drug development with “Fit-for-Purpose” modeling informed approaches
Exposure-safety Markov modeling of ocular adverse events in patient populations treated with tisotumab vedotin
Practical guide to concentration-QTc modeling: a hands-on tutorial
The dawn of a new era: can machine learning and large language models reshape QSP modeling?
EUVIMED